Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01899339 · ClinicalTrials.gov registry record
Long Term Effects of Treating Submassive Pulmonary Embolism With Ultra-sound Accelerated Thrombolysis
A clinical trial, sponsored by Corewell Health West.
- Completed
- Registry status
- 25
- Enrollment target
NCT01899339 is a clinical trial that has completed, run by Corewell Health West. The registered enrollment target is 25 participants.
The verdict
NCT01899339 has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Patients with Submassive Pulmonary Embolism treated with ultra-sound therapy will have an improved right ventricular function 72 hours post treatment.
Interventions
- OTHER submassive PA treatment with Ekosonic endo device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-05 |
| Est. Completion | 2019-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01899339
The ClinicalTrials.gov registry entry for NCT01899339 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which submassive PA treatment with Ekosonic endo device is the first listed.
NCT01899339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01899339 about?
NCT01899339 is a clinical study titled "Long Term Effects of Treating Submassive Pulmonary Embolism With Ultra-sound Accelerated Thrombolysis". Patients with Submassive Pulmonary Embolism treated with ultra-sound therapy will have an improved right ventricular function 72 hours post treatment.
What is the current status of trial NCT01899339?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2013-05. Estimated completion is 2019-02.
What interventions are being tested in trial NCT01899339?
The interventions under investigation include: submassive PA treatment with Ekosonic endo device (OTHER).
Who is sponsoring clinical trial NCT01899339?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.